Trifluorothymidine 0.5% ointment in the treatment of aciclovir-resistant mucocutaneous herpes simplex in AIDS.
Amin
A R
AR
Robinson
M R
MR
Smith
D D
DD
Swenson
C F
CF
Luque
A E
AE
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000212:Acyclovir / Q000494:pharmacology; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004351:Drug Resistance; D006566:Herpesviridae Infections / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D008297:Male; D018139:Simplexvirus / Q000187:drug effects*; D012867:Skin / Q000821:virology; D014271:Trifluridine / Q000627:therapeutic use*; D014412:Tumor Virus Infections / Q000188:drug therapy* / Q000378:metabolism
D000998:Antiviral Agents; D014271:Trifluridine; D000212:Acyclovir